ABBOTT LABORATORIES (ABT)
Abbott Laboratories (ABT) is a diversified healthcare company engaged in the discovery, development, manufacture, and distribution of pharmaceutical drugs, diagnostic tests, medical devices, and nutritional products. The company operates globally and serves healthcare providers, patients, and consumers across multiple therapeutic areas and customer segments.
What the company does
Abbott operates across four main business segments: pharmaceuticals, diagnostics, medical devices, and nutritional products. The pharmaceutical division develops treatments for cardiovascular disease, oncology, immunology, and other areas. The diagnostics segment provides laboratory testing systems and point-of-care diagnostic devices. The medical device division manufactures products for vascular intervention, structural heart disease, and other specialties. The nutritional segment markets vitamins, infant formula, and other supplements to consumers and healthcare systems.
How it makes money
Abbott generates revenue through the sale of branded and generic pharmaceutical products, diagnostic equipment and reagents, medical devices for therapeutic and diagnostic use, and nutritional products sold through pharmacy, hospital, and consumer channels. The company distributes through direct sales forces, wholesalers, pharmacies, hospitals, and retail outlets globally. Pricing varies by therapeutic category, geography, and payer mix.
Scale and market position
Abbott is one of the larger diversified healthcare companies globally, with operations in more than 160 countries. The company competes with integrated pharmaceutical firms, specialized device manufacturers, diagnostics leaders, and nutritional product companies across each of its business segments. Its scale and diversification provide both operational advantages and exposure to multiple product categories and markets.
Research and development
Abbott maintains substantial research and development capabilities focused on bringing new therapies and diagnostics to market. The company invests in drug discovery, device innovation, and diagnostic technology. Development timelines vary widely—diagnostics and devices may reach market faster than novel pharmaceuticals, which face extended regulatory review periods.
How to research it
Investors and stakeholders can access Abbott’s 10-K annual reports and 10-Q quarterly filings through the SEC’s EDGAR database. These documents provide detailed revenue breakdowns by segment and geography, pipeline information, R&D spending, manufacturing capacity, and regulatory compliance status. Earnings call transcripts and investor presentations offer additional perspective on business strategy and performance outlook.